CSIMarket
 

Biodelivery Sciences International Inc   (NASDAQ: BDSI)

Biodelivery Sciences International Inc 's

Competitiveness




 

BDSI Sales vs. its Competitors Q4 2019



Comparing the current results to its competitors, Biodelivery Sciences International Inc reported Revenue increase in the 4 quarter 2019 by 75.49 % year on year.
The sales growth was above Biodelivery Sciences International Inc 's competitors' average revenue growth of 69.74 %, achieved in the same quarter.

• List of BDSI Competitors





Revenue Growth Comparisons




Net Income Comparison


Biodelivery Sciences International Inc recorded a net loss, as well as most of its competitors.

<<  BDSI Stock Performance Comparisons



  

Overall company Market Share Q4 2019

Due to outstanding performance in Overall company, revenue grew by 75.49 % Biodelivery Sciences International Inc has increased its market share in this segment.




<<  More on BDSI Market Share.
 
*Market share is calculated based on total revenue.





Publicly Traded Peers of Biodelivery Sciences International Inc




Avenir Wellness Solutions Inc
Share Performance



0.00%
Over The Past 5 Days



Avenir Wellness Solutions Inc
Profile

Avenir Wellness Solutions Inc is a health and wellness company that operates through a subscription-based model. They offer personalized wellness programs, incorporating nutrition, fitness, and mental health, to their members. With a focus on providing comprehensive and tailored services, Avenir Wellness Solutions Inc aims to promote overall well-being and help individuals achieve their health goals.

More about Avenir Wellness Solutions Inc 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 0.016 mill. $ 2.045 mill. $ -2.757 mill.


Intelgenx Technologies Corp
Share Performance



+8.97%
This Quarter



Intelgenx Technologies Corp
Profile

Intelgenx Technologies Corp is a pharmaceutical company that focuses on developing and manufacturing innovative drug delivery solutions through collaboration with global pharmaceutical partners. Their business model revolves around licensing their advanced oral film technology, VersaFilm, to these partners for the development and commercialization of their own pharmaceutical products.

More about Intelgenx Technologies Corp 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 28.644 mill. $ 1.042 mill. $ -11.030 mill.

Sources: Biodelivery Sciences International Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Biodelivery Sciences International Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.